Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine.
Researchers led by Hening Lin have found a new way to potentially treat inflammatory bowel disease, as well as other autoimmune disorders, by targeting a mechanism that regulates the signaling pathway that enables inflammation to occur.
Jeff Niederdeppe, associate professor of communication at Cornell University, studies the mechanisms and effects of mass media campaigns, strategic health messages and news coverage in shaping health behavior. He says the potential restrictions highlight how flavored e-cigarettes are directly targeted toward young people.
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, according to a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cases of symptomatic COVID-19 were extremely low among children and staff at a network of North Carolina YMCA day camps that took precautions like masking and physical distancing, researchers have found.
Cornell researchers developed an imaging tool to create intricate spatial maps of the locations and identities of hundreds of different microbial species, such as those that make up the gut microbiome.
A new Android app developed by Cornell Tech researchers and collaborators will make it easy for people to collect their personal health data and share it with trusted medical providers or apps.
The university launched its COVID-19 testing program for students July 16 as part of a multipronged public health effort. The initial focus is “arrival testing,” in which students are tested upon their return to the Ithaca area.
A new study has uncovered key details for how the Salmonella bacteria that causes typhoid fever identifies a host’s immune cells and delivers toxins that disrupt the immune system and allow the pathogen to spread.
